Old Web
English
Sign In
Acemap
>
authorDetail
>
Yongyi Zhong
Yongyi Zhong
Sun Yat-sen University
Oncology
Internal medicine
Randomized controlled trial
Breast cancer
Hormone receptor
3
Papers
18
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study:
2021
Therapeutic Advances in Medical Oncology
Yanhong Su
Yarui Zhang
Xin Hua
Jiajia Huang
Xiwen Bi
Wen Xia
Xinyue Wang
Zhangzan Huang
Chen Ge Song
Yongyi Zhong
Yanxia Shi
Shusen Wang
Wei Fan
Zhongyu Yuan
Show All
Source
Cite
Save
Citations (1)
Trastuzumab plus endocrine therapy or chemotherapy as first-line treatment for metastatic breast cancer with hormone receptor-positive and HER2-positive: The sysucc-002 randomized clinical trial.
2021
Journal of Clinical Oncology
Zhongyu Yuan
Jiajia Huang
Xin Hua
Jian-Li Zhao
Ying Lin
Yuan Qi Zhang
Zhiyong Wu
Lehong Zhang
Xiwen Bi
Wen Xia
Yongyi Zhong
Shusen Wang
Fei Xu
Ruoxi Hong
Kuikui Jiang
Yanxia Shi
Cong Xue
Xin An
Show All
Source
Cite
Save
Citations (1)
The Effects of Ganglioside-Monosialic Acid in Taxane-induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial
2019
Journal of the National Cancer Institute
Yanhong Su
Jiajia Huang
Shusen Wang
Joseph M. Unger
Jonathan Arias-Fuenzalida
Yanxia Shi
Jibin Li
Yongxiang Gao
Wei Shi
Xinyue Wang
Roujun Peng
Fei Xu
Xin An
Cong Xue
Wen Xia
Ruoxi Hong
Yongyi Zhong
Ying Lin
Heng Huang
Anqin Zhang
Lehong Zhang
Li Cai
Jinxin Zhang
Zhongyu Yuan
Show All
Source
Cite
Save
Citations (16)
1